The scientific conference “Innovation and Equity in Addressing Metabolic Dysfunction-Associated Fatty Liver Disease: A Commitment to People Living with Obesity,” held today at the headquarters of the Spanish Medical Association (OMC) on the occasion of World Obesity Day, concluded with the approval of the Madrid Declaration on Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD), a document […]
Javier Crespo will participate in the scientific and social conference “Innovation and Equity in Addressing Metabolic-Associated Fatty Liver Disease. A Commitment to People Living with Obesity,” to be held on March 4 at the headquarters of the Spanish Medical Association (OMC), coinciding with World Obesity Day. The meeting will bring together experts from different disciplines […]
The Santander Biomedical Lectures program held a new session featuring Fernando Rivadeneira, Professor of Translational Genomics at Erasmus MC and an internationally recognized leader in genetics, clinical epidemiology, and musculoskeletal diseases, honored with distinctions such as the Fuller Albright Award. During his lecture, entitled “Clinical Applications of Polygenic Risk Scores,” he delivered a clear and […]
The Marqués de Valdecilla Research Institute (IDIVAL) announces the upcoming launch of the 2026 call for proposals of the NEXT-VAL Program, an initiative aimed at promoting the development of translational research projects within the biosanitary environment of Cantabria. The program is intended for emerging principal investigators who have not previously obtained competitive funding as principal […]
The Marqués de Valdecilla Research Institute (IDIVAL) and the Health Department of the Government of Cantabria are organizing the 4th edition of the National Forum on Innovation Management in Health – Building Minds, an event that has already become a benchmark space for the exchange of knowledge, experiences, and reflection on innovation in the healthcare […]
Paula Iruzubieta, a specialist in Digestive Diseases at the Marqués de Valdecilla University Hospital and a researcher in the field of hepatology, has been selected in the INNVAL 2025 call for proposals. Her project, called ESPERANZA, proposes a new care strategy to improve risk stratification in patients with metabolic dysfunction–associated steatotic liver disease (MASLD), one […]
A European study led by IDIVAL confirms fewer hernias and better quality of life without affecting oncological outcomes The Surgical Innovation and Research Group of the Marqués de Valdecilla Health Research Institute (IDIVAL) has published a new article from the European MIRCAST project, the largest prospective multicenter study to date on minimally invasive right colectomy. […]
The call, published in the Official Gazette of Cantabria (BOC) on February 18, 2026, promotes talent recruitment, innovation, internationalization, and patient-based studies. The Marqués de Valdecilla Research Institute (IDIVAL) has launched eight biomedical research promotion programmes under the 2026 call of the PLADIBIO programme, published in the Official Gazette of Cantabria (BOC) on February 18 […]
The conference “Preventing Frailty from Primary and Community Care: Lessons Learned and Challenges,” organized by the Marqués de Valdecilla Research Institute (IDIVAL) together with the Cantabrian Health Service (SCS), brought together healthcare and social professionals, researchers, community stakeholders, and citizens to address one of the main challenges associated with aging: frailty. The meeting, led by […]
The Marqués de Valdecilla Health Research Institute (IDIVAL) has awarded one of the projects from its INNVAL program to researcher Paula Paras, a nurse, physiotherapist, and PhD in Health Sciences, to create and validate the first comprehensive tool designed to consistently assess elimination ostomies and their complications. The initiative aims to address a widely recognized […]
Biomedical research and innovation are only possible thanks to everyone’s collaboration. This is how we move forward in improving the health of patients and the wider community